Influence of the Coronavirus Disease 2019 Pandemic on Patients with ST-Segment Elevation Myocardial Infarction in Taiwan
Table 2
Angiographic feature, results, and clinical outcomes.
Variables
Group 1
Group 2
value
February to April 2016–2019 (n = 130)
February to April 2020 (n = 28)
Symptom-to-door time (hours)
1.8 (0.9–3.0)
1.3 (0.9–2.7)
0.532
Door-to-ECG time (minutes)
6 (4–8)
5 (4–9)
0.741
Door-to-cath room time (minutes)
38 (32–56)
43 (33–124)
0.532
Reperfusion time (minutes)
18 (14–23)
19 (15–27)
0.514
Door-to-balloon time (minutes)
59 (48–78)
62 (52–150)
0.243
Door-to-balloon time < 90 minutes
106 (81.5)
18 (64.3)
0.044
Postprocedural TIMI-3 flow
126 (96.9)
27 (96.4)
0.892
Stenting
124 (95.4)
28 (100)
0.246
Multivessel disease (≥2 vessels)
87 (66.9)
19 (67.9)
0.924
Length of hospital stay (days)
4.6 (3.5–6.8)
3.7 (3.0–5.5)
0.699
LVEF
55 (46–55)
59 (46–69)
0.858
In-hospital mortality
11 (8.5)
1 (3.6)
0.376
Data are expressed as mean ± SD or n (%) or median (25th–75th percentile). ECG: electrocardiography; LVEF: left ventricular ejection fraction; TIMI: thrombolysis in myocardial infarction. < 0.05.